Impaired learning in rats in a 14-unit T-maze by 7-nitroindazole, a neuronal nitric oxide synthase inhibitor, is attenuated by the nitric oxide donor, molsidomine

European Journal of Pharmacology

Volumn 341, Issue 1, 1998, Pages 17-22

  Meyer, Robert C ^a   Spangler, Edward L ^a   Patel, Namisha ^a   London, Edythe D ^b   Ingram, Donald K ^a  

^a Nathan W Shock Labs G   (United States)

^b Brain Imaging Section   (United States)

Author keywords

Blood pressure; Ca2+; Glutamate; Memory; Neurotransmitter; NMDA (N methyl D aspartate)

Indexed keywords

7 NITROINDAZOLE; MOLSIDOMINE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; LEARNING DISORDER; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTOLIC BLOOD PRESSURE;

ANIMALS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENZYME INHIBITORS; INDAZOLES; MALE; MAZE LEARNING; MOLSIDOMINE; NEURONS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; RATS, INBRED F344; VASODILATOR AGENTS;

EID: 0032472416     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01428-3     Document Type: Article

References (34)

1. Bannerman D.M., Chapman P.F., Kelly P.A.T., Butcher S.P., Morris R.G.M. Inhibition of nitric oxide synthase does not impair spatial learning. J. Neurosci. 14:1994;7404-7414.
2. Bear M.F. A synaptic basis for memory storage in the cerebral cortex. Proc. Natl. Acad. Sci. USA. 93:1996;13453-13459.
3. Beierwaltes W.H. Selective neuronal nitric oxide synthase inhibition blocks furosemide-stimulated renin secretion in vivo. Am. J. Physiol. 269:1995;134-139.
4. Boger R.H., Bode-Boger S.M., Gerecke U., Frolich J.C. Long-term administration of L-arginine, L-NAME, and the exogenous NO donor molsidomine modulates urinary nitrate and cGMP excretion in rats. Cardiovasc. Res. 28:1994;494-499.
5. Chapman P.F., Atkins C.M., Allen M.T., Haley J.E., Steinmetz J.E. Inhibition of nitric oxide synthesis impairs two different forms of learning. Neuroreport. 3:1992;567-570.
6. Dragunow M. A role for immediate-early transcription factors in learning and memory. Behav. Genet. 26:1996;293-299.
7. Estall L.B., Grant S.J., Cicala G.A. Inhibition of nitric oxide (NO) production selectively impairs learning and memory in the rat. Pharmacol. Biochem. Behav. 46:1993;959-962.
8. Garthwaite J., Garthwaite G., Palmer R.M., Moncada S. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur. J. Pharmacol. 172:1989;413-416.
9. Granger J., Novak J., Schnackenberg C., Williams S., Reinhart G.A. Role of renal nerves in mediating the hypertensive effects of nitric oxide synthesis inhibition. Hypertension. 27:1996;613-618.
10. Handy R.L., Wallace P., Gaffen Z.A., Whitehead K.J., Moore P.K. The antinociceptive effect of 1-(2-trifluoromethylphenyl) imidazole (TRIM), a potent inhibitor of neuronal nitric oxide synthase in vitro, in the mouse. Br. J. Pharmacol. 116:1995;2349-2350.
11. Holscher C., Canevari L., Richter-Levin G. Inhibitors of PLA2 and NO synthase cooperate in producing amnesia of a spatial task. Neuroreport. 6:1995;730-732.
12. Ingram, D.K., Shimada, A., Spangler, E.L., Ikari, H., Hengemihle, J., Kuo, H., Greig, N., 1996. Cognitive enhancement: New strategies for stimulating cholinergic, glutamatergic, and nitric oxide systems. In: Pharmacologic Intervention Aging and Age-Associated Disorders. Annals of the New York Academy of Sciences, vol. 786, pp. 348-361.
13. ω-nitro-l-arginine. Eur. J. Pharmacol. 341:1997;1-7.
14. ω-nitro-L-arginine, in rats impairs learning in a 14-unit T-maze. Eur. J. Pharmacol. 341:1997;11-16.
15. Kelly P.A., Ritchie I.M., Arbuthnott G.W. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole: Effects upon local cerebral blood flow and glucose use in the rat. J. Cerebr. Blood Flow Metab. 15:1995;766-773.
16. Mondadori C., Weiskrantz L. NMDA receptor blockers facilitate and impair learning via different mechanisms. Behav. Neural Biol. 60:1993;205-210.
17. Mondadori C., Weiskrantz L., Buerki H., Petschke F., Fagg G.E. NMDA receptor antagonists can enhance or impair learning performance in animals. Exp. Brain Res. 75:1989;449-456.
18. Montecot C., Borrendon J., Seylaz J., Pinard E. Nitric oxide of neuronal origin is involved in cerebral blood flow increase during seizures induced by kainate. J. Cerebr. Blood Flow Metab. 17:1997;94-99.
19. Moore P.K., Wallace P., Gaffen Z., Hart S.L., Babbedge R.C. Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: Antinociceptive and cardiovascular effects. Br. J. Pharmacol. 110:1993;219-224.
20. Morris, R.G.M., Davis, S., Butcher, S.P., 1989. The role of NMDA receptors in learning and memory. In: Watkins, J.C., Collingbridge, G.L. (Eds.), The NMDA receptor. IRL Press, Oxford, pp. 137-151.
21. Muller W.E., Scheuer K., Stoll S. Glutamatergic treatment strategies for age-related memory disorders. Life Sci. 55:1994;2147-2153.
22. ω-nitro-L-arginine to prevent the formation of an olfactory memory in mice. Physiol. Behav. 58:1995;387-391.
23. G-L-arginine methyl ester, dose dependently reduce the threshold for isoflurane anesthesia. Anesthesiology. 85:1996;1111-1119.
24. Papa M., Pellicano M.P., Sadile A.G. Nitric oxide and long-term habituation to novelty in the rat. Ann. NY Acad. Sci. 738:1994;316-324.
25. Rison R.A., Stanton P.K. Long-term potentiation and N-methyl-D-aspartate receptors: foundations of memory and neurologic disease? Neurosci. Biobehav. Rev. 19:1995;533-552.
26. Robertson J.D., Bonaventura J., Kohm A.P. Nitric oxide is required for tactile learning in Octopus vulgaris. Proc. R. Soc. Lond. B: Biol. Sci. 256:1994;269-273.
27. Sandi C., Venero C., Guaza C. Decreased spontaneous motor activity and startle response in nitric oxide synthase inhibitor-treated rats. Eur. J. Pharmacol. 277:1995;89-97.
28. Schuman E.M., Madison D.V. Locally distributed synaptic potentiation in the hippocampus. Science. 263:1994;532-536.
29. Segovia G., Porras A., Mora F. Effects of a nitric oxide donor on glutamate and GABA release in striatum and hippocampus of the conscious rat. Neuroreport. 5:1994;1937-1940.
30. Son H., Hawkins R.D., Martin K., Kiebler M., Huang P.L., Fishman M.C., Kandel E.R. Long-term potentiation is reduced in mice that are doubly mutant in endothelial and neuronal nitric oxide synthase. Cell. 87:1996;1015-1023.
31. Swislocki A., Eason T., Kaysen G.A. Oral administration of the nitric oxide biosynthesis inhibitor, N-nitro-L-arginine methyl ester (L-NAME), causes hypertension, but not glucose intolerance or insulin resistance in rats. Am. J. Hypertens. 8:1995;1009-1014.
32. Tobin J.R., Gorman L.K., Baxter M.G., Traystman R.J. Nitric oxide synthase inhibition does not impair visual or spatial discrimination learning. Brain Res. 694:1995;177-182.
33. Vaupel D.B., Kimes A.S., London E.D. Nitric oxide synthase inhibitors. Preclinical studies of potential use for treatment of opioid withdrawal. Neuropsychopharmacology. 13:1995;315-322.
34. Yamada K., Hiramatsu M., Noda Y., Mamiya T., Murai M., Kameyama T., Komori Y., Nikai T., Sugihara H., Nabeshima T. Role of nitric oxide and cyclic GMP in the dizocilpine-induced impairment of spontaneous alternation behavior in mice. Neuroscience. 74:1996;365-374.